Aller au contenu principal
Accès ouvert déclaré 2025 article

Genome-wide association study of 398,238 women unveils seven loci associated with high-grade serous ovarian cancer

0Citations signalées — pas une note de qualité
181Institutions déclarées
26Pays d’affiliation déclarés

Résumé fourni par la source

Abstract Nineteen genomic regions have been associated with high-grade serous ovarian cancer (HGSOC). We meta-analyzed >22 million variants for 398,238 women from the Ovarian Cancer Association Consortium (OCAC), UK Biobank (UKBB) and Consortium of Investigators of Modifiers of BRCA1 / BRCA2 (CIMBA) to identify novel HGSOC susceptibility loci. Eight novel variants were associated with HGSOC risk. An interesting discovery biologically was TP53 3’-UTR SNP rs78378222-T’s association with HGSOC (per-T-allele relative risk (RR) = 1.44, 95% CI:1.28–1.62, P = 1.76 × 10 −9 ). Polygenic scores (PGS) were developed using OCAC and CIMBA data and trained on FinnGen data. The optimal PGS included 64,518 variants and was associated with an odds ratio of 1.46 (95% CI:1.37–1.54) per standard deviation when validated in the UKBB. This study represents the largest HGSOC GWAS to date – demonstrating that improvements in imputation reference panels and increased sample sizes help to identify HGSOC associated variants that previously went undetected, ultimately improving PGS which can improve personalized HGSOC risk prediction.

Ce résumé expose les affirmations des auteurs. BNTIC ne l’interprète pas comme une validation indépendante des résultats.

Contrôle bibliographique ouvert

DOI retrouvé dans Crossref DOI retrouvé ; titre concordant.

Titre Crossref
Genome-wide association study of 398,238 women unveils seven loci associated with high-grade serous ovarian cancer
Date Crossref
20/11/2025
Éditeur
Springer Science and Business Media LLC
Type
journal-article

Ce recoupement confirme des métadonnées liées au DOI. Il ne confirme ni la méthode ni les conclusions de l’étude et ne compte pas comme une seconde source scientifique indépendante.

Institutions déclarées

University of CambridgeCancer Research UKThe Ohio State UniversityUniversity of HelsinkiHelsinki University HospitalInsermUniversité Paris Sciences et LettresÉcole Nationale Supérieure des Mines de ParisInstitut CurieUniversity of TorontoLunenfeld-Tanenbaum Research InstituteSinai Health SystemUniversity of California, IrvineUniversity of IcelandNational University Hospital of IcelandThe University of Texas MD Anderson Cancer CenterVall d'Hebron Hospital UniversitariVall d'Hebron Institute of OncologyRutgers, The State University of New JerseyRutgers Cancer InstituteUniversity Medical Center GroningenUniversity of GroningenInstitute of Cancer ResearchNormandie UniversitéCentre François BaclesseUniversité de Rouen NormandiePomeranian Medical UniversityHaukeland University HospitalUniversity of BergenUniversity of California, San FranciscoCancer Genetics (United States)Maastricht UniversityCity of HopeResearch Network (United States)Medizinische Hochschule HannoverN.N. Alexandrov National Cancer CentreNational Institute of OncologyUniversity of UtahHuntsman Cancer InstituteIstituto di Genetica MolecolarePeter MacCallum Cancer CentreInstitut d'Investigació Biomédica de BellvitgeInstitut Català d'OncologiaGhent University HospitalGhent UniversityCancer Research Institute GhentColorado School of Public HealthUniversity of Colorado AnschutzFox Chase Cancer CenterThe Maria Sklodowska-Curie National Research Institute of OncologyInstituto de Investigación Sanitaria del Hospital Clínico San CarlosCentro de Investigación Biomédica en Red de CáncerThe University of SydneyWestmead HospitalWestmead Institute for Medical ResearchCancer Council NSWUniversity of ChicagoEvanston HospitalBeckman Research InstituteUniversity of PennsylvaniaUniversity of GothenburgLeipzig UniversityManchester Academic Health Science CentreUniversity of ManchesterSt Mary's HospitalMasaryk Memorial Cancer InstituteNorwegian Institute of Public HealthGerman Cancer Research CenterHeidelberg UniversityCancer Registry of NorwayNational Centre of Scientific Research "Demokritos"Istituto Oncologico VenetoIstituti di Ricovero e Cura a Carattere ScientificoTel Aviv UniversitySheba Medical CenterAssuta Medical CenterNational Cancer InstituteDivision of Cancer Epidemiology and GeneticsUCLA Jonsson Comprehensive Cancer CenterMRC Clinical Trials Unit at UCLUniversity College LondonUniversity of Kansas Medical CenterSpanish National Cancer Research CentreCentre for Biomedical Network Research on Rare DiseasesEuropean Institute of OncologyUniversity of CopenhagenCopenhagen University HospitalRigshospitaletUniversity of WashingtonFred Hutch Cancer CenterUniversity of CologneUniversity Hospital CologneKliniken Essen-MitteThe Netherlands Cancer InstituteErasmus MC Cancer InstituteThe University of MelbourneBC Cancer AgencyUniversity of British ColumbiaVancouver General HospitalInstitute of Oncology NN PetrovGuy's and St Thomas' NHS Foundation TrustVilnius UniversityState Research Institute Centre for Innovative MedicineStanford UniversityCedars-Sinai Medical CenterUniversity of California, Los AngelesRadboud University NijmegenRadboud University Medical CenterTechnion – Israel Institute of TechnologyCarmel Medical CenterUniversidade de Santiago de CompostelaComplejo Hospitalario Universitario de SantiagoFundación Pública Galega de Medicina XenómicaInstituto de Investigación Sanitaria de SantiagoServicio Gallego de SaludUniversity of PittsburghMagee-Womens HospitalFondazione IRCCS Istituto Nazionale dei TumoriPrincess Margaret Cancer CentreOvarian Cancer ActionImperial College LondonUniversity of GlasgowCancer Council VictoriaMonash HealthMonash UniversityMagee-Womens Research InstituteCancer Research CenterUPMC Hillman Cancer CenterBrigham and Women's HospitalHarvard UniversityRoswell Park Comprehensive Cancer CenterAix-Marseille UniversitéInstitut Paoli-CalmettesEconomic & Social Sciences, Health Systems & Medical InformaticsInstitut de Recherche pour le DéveloppementHospital Universitario Fundación Jiménez DíazInstituto de Investigación Sanitaria Fundación Jiménez DíazUniversidad Autónoma de MadridUniversity of FlorenceUniversity of Southern CaliforniaUniversity of MichiganAalborg University HospitalAalborg UniversityInstituto Português de Oncologia Francisco GentilIPO PortoProvidence Medford Medical CenterGeorgetown UniversityGeorgetown University Medical CenterUfa Institute of ChemistryInstitut d'Investigació Biomèdica de GironaShaukat Khanum Memorial Cancer Hospital and Research CenterUniversity of BristolMRC Epidemiology UnitNational Institute of Environmental Health SciencesIcahn School of Medicine at Mount SinaiComprehensive Cancer Center ViennaMedical University of ViennaSt George’s University Hospitals NHS Foundation TrustCentre hospitalier universitaire de QuébecUniversité LavalUniversité Paris CitéUniversity of South FloridaUniversity Hospital HeidelbergUniversidade do PortoNational Institute for Health and Care ResearchKU LeuvenInstituto de Investigación de Enfermedades RarasVanderbilt University Medical CenterQIMR Berghofer Medical Research InstituteThe University of Kansas Cancer CenterMayo ClinicMayo Clinic in ArizonaDuke University HospitalMoffitt Cancer CenterMemorial Sloan Kettering Cancer CenterIo Therapeutics (United States)Cancer Institute of New South WalesYale UniversityUniversity of VirginiaUniversity of Southern DenmarkOdense University Hospital

Une affiliation ne permet pas de déduire la nationalité d’un auteur.

Sujets associés

BRCA gene mutations in cancerOvarian cancer diagnosis and treatmentGenetic Associations and Epidemiology

BNTIC News n’est pas le producteur de ces données. Recherche à la demande dans Crossref, OpenAIRE, DOAJ, Europe PMC, HAL, DataCite, ROR et la Banque mondiale, sans clé ; OpenAlex reste optionnel. Aucun service payant requis, aucune donnée externe enregistrée en base. Sources et limites.